APGE vs IR · $2.34B cap vs P/E 49, rev $3.90B
Apogee Therapeutics, Inc. Common Stock (APGE) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
APGE currently screens at market cap $2.34B. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the APGE and IR stock pages for the full models.
Not investment advice.